Abstract
Conservative treatment, consisting in uterine preservation with unilateral salpingo-oophorectomy, can be proposed to selected patients with early epithelial ovarian cancer, with a desire for pregnancy after a histological review and surgical staging.
This procedure can be safely proposed for common histological subtype (mucinous, serous and endometrioid), for stage IA grade 1 and 2, for stage IC1 grade 1 disease.
The literature review of oncological and fertility outcomes after fertility sparing surgery in patients with epithelial ovarian cancer shows: an overall recurrence rate of 12%, a median overall survival of 94% at 5 years, a rate of 43% patients willing a pregnancy of which 66% become pregnant.
Assisted conception procedures after conservative treatment are actually contraindicated, nevertheless many techniques for fertility preservation are now developed.
Follow-up is based on a clinical examination, an analysis of tumour markers and the use of systematic imaging, at least every 4 months for the first 2 years, then every 6 months until 5 years and every year thereafter. Test for BRCA1-2 mutations is indicated.
Completion surgery after childbearing, or after 40 years of age in patients who have not become pregnant, is recommended.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1–5.
Morice P, Denschlag D, Rodolakis A, et al. Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors. Int J Gynecol Cancer. 2011;21:951–63.
DiSaia PJ. Conservative management of the patient with early gynecologic cancer. CA Cancer J Clin. 1989;39:135–54.
Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol. 1994;55:S47–51.
Zanetta G, Chiari S, Rota S, et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol. 1997;104:1030–5.
Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002;87:1–7.
Morice P, Leblanc E, Rey A, et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d’Oncologie Gynécologique). Hum Reprod. 2005;20:1379–85.
Park JY, Kim DY, Suh DS, et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol. 2008;110:345–53.
Anchezar JP, Sardi J, Soderini A. Long-term follow-up results of fertility sparing surgery in patients with epithelial ovarian cancer. J Surg Oncol. 2009;100:55–8.
Satoh T, Hatae M, Watanabe Y, et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol. 2010;28:1727–32.
Fruscio R, Corso S, Ceppi L, et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol. 2013;24:138–44.
Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet. 1989;96(8):889–92.
Kajiyama H, Mizuno M, Shibata K, et al. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study. Eur J Obstet Gynecol Reprod Biol. 2014;175:97–102.
Kashima K, Yahata T, Fujita K, Tanaka K. Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer. Int J Gynaecol Obstet. 2013;121(1):53–5.
Wright JD, Shah M, Mathew L, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009;115(18):4118–26.
Ditto A, Martinelli F, Bogani G, et al. Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures. Gynecol Oncol. 2015;138(1):78–82.
Petrillo M, Legge F, Ferrandina G, et al. Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature. Gynecol Obstet Invest. 2014;77:1–5.
Lee JY, Jo YR, Kim TH, et al. Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary. Cancer Res Treat. 2015;47(2):290–7.
Kajiyama H, Shibata K, Suzuki S, et al. Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary? Gynecol Oncol. 2008;111:523–6.
Raspagliesi F, Fontanelli R, Paladini D, di Re EM. Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg. 1997;185(5):457–60.
Borgfeldt C, Iosif C, Måsbäck A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):110–4.
Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer. 2009;19(7):1199–204.
Kwon YS, Hahn HS, Kim TJ, et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol. 2009;20(1):44–7.
Kajiyama H, Shibata K, Suzuki S, et al. Fertility-sparing surgery in young women with invasive epithelial ovarian cancer. Eur J Surg Oncol. 2010;36(4):404–8.
Cheng X, Cheng B, Wan X, Lu W, Xie X. Outcomes of conservative surgery in early epithelial ovarian carcinoma. Eur J Gynaecol Oncol. 2012;33(1):93–5.
Marpeau O, Schilder J, Zafrani Y, et al. Prognosis of patients who relapse after fertility-sparing surgery in epithelial ovarian cancer. Ann Surg Oncol. 2008;15:478–83.
Du Bois A, Heitz F, Harter P. Fertility-sparing surgery in ovarian cancer: a systematic review. Onkologie. 2013;36(7–8):436–43.
Zapardiel I, Diestro MD, Aletti G. Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol. 2014;40:387–93.
Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg. 2003;197:198–205.
Cho YH, Kim DY, Kim JH, et al. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? Gynecol Oncol. 2006;103:878–82.
Schmeler KM, Tao X, Frumovitz M, et al. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol. 2010;116(2 Pt 1):269–73.
Munnell EW. Is conservative therapy ever justified in stage I (IA) cancer of the ovary ? Am J Obstet Gynecol. 1969;103:641–50.
Benjamin I, Morgan MA, Rubin SC. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol. 1999;72:288–91.
Leblanc E, Querleu D, Narducci F, Occelli B, Papageorgiou T, Sonoda Y. Laparoscopic staging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol. 2004;94:624–9.
Nezhat FR, Ezzati M, Chuang L, Shamshirsaz AA, Rahaman J, Gretz H. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol. 2009;200:83.
Ghezzi F, Malzoni M, Vizza E, et al. Laparoscopic staging of early ovarian cancer: results of a multi-institutional cohort study. Ann Surg Oncol. 2012;19:1589–94.
Tozzi R, Köhler C, Ferrara A, Schneider A. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol. 2004;93:199–203.
Schreuder HW, Pattij TO, Zweemer RP, van Baal MW, Verheijen RH. Increasing experience in laparoscopic staging of early ovarian cancer. Gynecol Surg. 2012;9:89–96.
Montanari G, Di Donato N, Del Forno S, et al. Laparoscopic management of early stage ovarian cancer: is it feasible, safe, and adequate? A retrospective study. Eur J Gynaecol Oncol. 2013;34(5):415–8.
Finger TN, Nezhat FR. Robotic-assisted fertility-sparing surgery for early ovarian cancer. JSLS. 2014;18(2):308–13.
Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;243:437–50.
Noyes N, Labella PA, Grifo J, Knopman JM. Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. J Assist Reprod Genet. 2010;27:495–9.
Huang JYJ, Chian RC, Gilbert L, et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients. AJS. 2010;200:177–83.
Berwanger AL, Finet A, El Hachem H, le Parco S, Hesters L, Grynberg M. New trends in female fertility preservation: in vitro maturation of oocytes. Future Oncol. 2012;8(12):1567–73.
Bandera CA, Cramer DW, Friedman AJ, Sheets EE. Fertility therapy in the setting of a history of invasive epithelial ovarian cancer. Gynecol Oncol. 1995;58(1):116–9.
Grynberg M, Poulain M, Sebag-Peyrelevade S, le Parco S, Fanchin R, Frydman N. Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil Steril. 2012;97(6):1260–8.
Fortin A, Hazout A, Thoury A, Alvès K, Bats AS, Dhainaut C, Madelenat P. Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours. Gynecol Obstet Fertil. 2005;33(7–8):488–97.
Fadini R, Dal Canto M, Mignini Renzini M, et al. Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. J Assist Reprod Genet. 2012;29(8):779–81.
Dittrich R, Hackl J, Lotz L, Hoffmann I, Beckmann MW. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103(2):462–8.
Moore MM, Tewari K, Rose GS, Fruehauf JP, DiSaia PJ. Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient. Gynecol Oncol. 1999;73(3):452–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bentivegna, E. et al. (2017). Oncofertility Applied to Epithelial Ovarian Cancer. In: Pujade-Lauraine, E., Ray-Coquard, I., Lécuru, F. (eds) Ovarian Cancers. Springer, Cham. https://doi.org/10.1007/978-3-319-32110-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-32110-3_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32108-0
Online ISBN: 978-3-319-32110-3
eBook Packages: MedicineMedicine (R0)